GIlead Sciences (GILD) stock is trading at record highs after announcing a top- and bottom-line beat for the fourth quarter ...

Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue? Over the past ...

COLUMBUS, Ohio (WCMH) — Girls at Hilltonia Middle School got a hands-on experience in health care science Tuesday. After ...

A South Korean life sciences company plans to open a genetic testing lab in North Austin, a move that could create up to 200 jobs. Last week, the Austin City Council approved a $200,000 economic ...

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q4 CY2025 results , with sales up 5.2% year on year to $7.93 billion. On the other hand, the company’s full-year revenue guidance of ...

They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...

Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA.

The new facility will cost $137 million and will house 18 research labs, four teaching labs, a 300-seat lecture hall, and ...

A professor and chair of UAMS’ Department of Orthopaedic Surgery, C. Lowry Barnes was selected as one of four finalists in a ...